Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$4.72
-4.1%
$4.48
$2.37
$6.18
$615.74M1.22748,501 shs4,172 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$13.43
+0.1%
$14.33
$5.30
$19.11
$1.14B1.761.21 million shs1,296 shs
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
$7.16
+1.5%
$8.14
$1.18
$12.20
$265.70M-0.931.28 million shs10,597 shs
Transcat, Inc. stock logo
TRNS
Transcat
$77.75
+1.6%
$76.08
$50.23
$97.08
$713.80M0.68128,576 shs122,043 shs
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-0.40%+7.89%+6.96%+10.07%+31.90%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+0.45%+1.59%-1.18%+0.83%+120.20%
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
-7.48%-8.08%-19.34%-19.15%+363.82%
Transcat, Inc. stock logo
TRNS
Transcat
+1.78%+0.53%+1.30%+0.22%-0.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$4.72
-4.1%
$4.48
$2.37
$6.18
$615.74M1.22748,501 shs4,172 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$13.43
+0.1%
$14.33
$5.30
$19.11
$1.14B1.761.21 million shs1,296 shs
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
$7.16
+1.5%
$8.14
$1.18
$12.20
$265.70M-0.931.28 million shs10,597 shs
Transcat, Inc. stock logo
TRNS
Transcat
$77.75
+1.6%
$76.08
$50.23
$97.08
$713.80M0.68128,576 shs122,043 shs
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-0.40%+7.89%+6.96%+10.07%+31.90%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+0.45%+1.59%-1.18%+0.83%+120.20%
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
-7.48%-8.08%-19.34%-19.15%+363.82%
Transcat, Inc. stock logo
TRNS
Transcat
+1.78%+0.53%+1.30%+0.22%-0.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.00
Hold$5.389.25% Upside
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$31.80137.14% Upside
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
1.00
SellN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
2.40
Hold$105.3337.69% Upside

Current Analyst Ratings Breakdown

Latest OPTX, EYPT, TRNS, and CTKB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Lower Price TargetOutperform$39.00 ➝ $37.00
5/4/2026
Transcat, Inc. stock logo
TRNS
Transcat
Reiterated RatingSell (D)
4/21/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Reiterated RatingSell (D-)
4/6/2026
Transcat, Inc. stock logo
TRNS
Transcat
DowngradeHoldStrong Sell
3/27/2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Reiterated RatingSell (D-)
3/9/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Boost Price TargetBuy$31.00 ➝ $35.00
3/5/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Boost Price TargetBuy$23.00 ➝ $30.00
3/4/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Boost Price TargetBuy$27.00 ➝ $29.00
3/4/2026
Transcat, Inc. stock logo
TRNS
Transcat
UpgradeStrong SellHold
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$201.49M3.15N/AN/A$2.67 per share1.84
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$31.37M35.82N/AN/A$3.70 per share3.62
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
$28.08M9.29$0.02 per share336.52$0.26 per share27.12
Transcat, Inc. stock logo
TRNS
Transcat
$319.69M2.23$4.34 per share17.61$30.82 per share2.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$66.54M-$0.51N/AN/AN/A-33.02%-7.70%-5.89%N/A
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$231.96M-$3.16N/AN/AN/A-3,566.63%-108.31%-88.87%N/A
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
-$1.79M-$0.05N/AN/AN/A-6.38%-17.19%-7.14%N/A
Transcat, Inc. stock logo
TRNS
Transcat
$14.52M$0.8590.0041.13N/A2.47%6.15%4.15%5/25/2026 (Estimated)

Latest OPTX, EYPT, TRNS, and CTKB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/25/2026Q4 2026
Transcat, Inc. stock logo
TRNS
Transcat
$0.5580N/AN/AN/A$89.79 millionN/A
5/7/2026Q1 2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.08-$0.15-$0.07-$0.15$44.23 million$44.14 million
5/6/2026Q1 2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.79-$0.99-$0.20-$0.99$0.35 million$0.70 million
3/31/2026Q4 2025
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
N/A-$0.01N/A-$0.01N/A$7.51 million
3/4/2026Q4 2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.78-$0.8143-$0.0343-$0.81$1.01 million$0.62 million
2/26/2026Q4 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$0.02-$0.34-$0.36-$0.34$58.80 million$62.14 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
N/AN/AN/AN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
5.04
4.42
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
8.88
8.83
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
0.37
1.35
0.65
Transcat, Inc. stock logo
TRNS
Transcat
0.34
2.21
1.85

Institutional Ownership

CompanyInstitutional Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
N/A
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.33%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
4.46%
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
0.83%
Transcat, Inc. stock logo
TRNS
Transcat
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500129.14 million115.80 millionOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12083.79 million80.06 millionOptionable
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
336.99 million36.69 millionN/A
Transcat, Inc. stock logo
TRNS
Transcat
1,2459.33 million9.07 millionOptionable

Recent News About These Companies

Transcat Names Jaime Irick as CEO
Transcat, Inc. (TRNS) Q3 2026 Earnings Call Transcript
Transcat: The Storm Has Passed (Upgrade)
Do You Believe in Transcat’s (TRNS) Potential to Recover?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$4.72 -0.20 (-4.07%)
As of 09:37 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$13.43 +0.02 (+0.12%)
As of 09:37 AM Eastern
This is a fair market value price provided by Massive. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Syntec Optics stock logo

Syntec Optics NASDAQ:OPTX

$7.16 +0.11 (+1.49%)
As of 09:37 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Syntec Optics Holdings, Inc. manufactures and supplies integrated optics for biomedical, defense and military, consumer, and other applications. It offers camera modules; tool design, design for manufacturing, optical and opto-mechanical design, and moldflow analysis; SPDT optics, such as freedom optics, microlens arrays, spheres and aspheres, diffractives, SPDT materials, and optical tooling; replicative molding, that includes polymer and glass molding, and molded production materials; thin film coating and coating curve materials; and precision machining and precision machining materials. The company also provides clean room assembly, such as opto mechanical, opto electronic, and integrated photonics; infrared optics, microlens arrays, software development, and optical metrology, and catalog optics services. In addition, it offers driverless cars, integrated photonics, robotics, sensors, VR and AR, machine vision, facial imagining, heads up display, finger print scanners, and laser scanners technology for consumers; night vision goggles, missile laser guides, biometrics, infrared and thermal imaging, ordnance optics, head mounted displays, 2D and 3D scanners, humvee lighting , laser targeting, protective domes and windows, and lidar technologies for defense and miliary; and medical diagnostic, microfluidics, surgical components and systems, and medical sensing technology for medical sectors. The company was founded in 1981 and is based in Rochester, New York.

Transcat stock logo

Transcat NASDAQ:TRNS

$77.74 +1.25 (+1.63%)
As of 09:37 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.